Eyebot $20M Series A Sales Trigger
Pipeline boost: Eyebot secures $20M Series A. Pitch self-serve vision-test kiosks, streamline patient flow, close deals faster.
Published on
Do not index
Do not index
π Battle Card: Eyebot
Quick trigger:
Β
π€ Decision Maker in the News
- Matthias Hofmann, PhD, Founder & CEO π§ mhofmann@eyebot.co
Β
π‘ Why It Matters
- Rapid, self-serve vision tests eliminate weeks-long waits and insurance hurdles for patients. This Eyebot sales trigger underscores the urgency of real-time, low-friction patient journeys. β Source
Β
π― Core Pain Point
- Lengthy prescription turnaround keeps clinics overloaded and patients frustrated
- High cost & insurance dependency blocks access for uninsured or underinsured patients
Β
π° What to Pitch
- Primary: Self-serve rapid vision-testing kiosks β Deliver doctor-verified prescriptions in under 2 minutes
- Expansion: Clinic management integration β Streamline patient throughput and boost margins
Β
πΊοΈ Quick Context
- HQ: Boston, MA / USA
- Employees: β 30
- Rev: β $1M
- Website: eyebot.co
Β
π€Ό Competitive Intel
Which other vendors youβll probably face to win Eyebotβs business.
Β
- Topcon Medical β Vision testing kiosks / diagnostic devices
- Unique edge: Established brand in ophthalmic hardware
- Evaluated by clinic directors for device durability
- Nidek β Automated refractors / diagnostic devices
- Unique edge: Precision optics with global support
- Evaluated by COO & IT for integration ease
- ZEISS β Ophthalmic diagnostic solutions
- Unique edge: High-accuracy patented technology
- Evaluated by VPs of Ops for quality assurance
- EssilorLuxottica β Lens crafting & testing solutions
- Unique edge: Vertical integration from lens to testing
- Evaluated by CFO for total cost of ownership
Β
β Do-Now Checklist
Connect with all decision makers on LinkedIn (links above)
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Leverage the Eyebot sales trigger in your outreach subject lines
Β
Next Step
Get more Eyebot sales trigger intel like this dailyβno fluff, all pipeline.
Subscribe to NewsletterForLeads
Β
π§ Copy My Prompt for Personalized Cold Outreach
ββββββββββββββββββββββββββββ
βοΈ YOUR COMPANY
ββββββββββββββββββββββββββββ
OUR_COMPANY = ββ
OFFER_BRIEF = βSelf-serve rapid vision-testing kiosks deliver doctor-verified prescriptions in under 2 minutesβ
PROOF_METRIC = β90-second vision tests verified by licensed doctorsβ
CTA_STYLE = βquick_callβ
TONE = βfriendlyβ
ββββββββββββββββββββββββββββ
π TARGET COMPANY
ββββββββββββββββββββββββββββ
NAME = Matthias
COMPANY = Eyebot
DEPT = β TBD
SIZE = β 30
BOTTLENECK = lengthy prescription turnaround
EVENT = $20M Series A financing
DETAIL = $20M Series A financing
PAIN = long waits for prescriptions frustrate patients
SRC = https://vcnewsdaily.com/eyebot/venture-capital-funding/xmkypcqsvw
SIM_CO = β TBD
WIN_METRIC = β TBD
NEXT_SIZE = β TBD
EMP_EST = β 30
REV_EST = β $1M
ββββββββββββββββββββββββ
TASK FOR CHATGPT
ββββββββββββββββββββββββ
Role: βNewsletterForLeads SDR-Assistβ.
Validate any β guesses via SRC.
EMAIL (keep breaks):
Subject: β 30-person β TBD
Matthiasβnoticed your β TBD team is β 30.
Thatβs when lengthy prescription turnaround slows growth.
We helped β TBD fix this with Self-serve rapid vision-testing kiosks deliver doctor-verified prescriptions in under 2 minutes.
Result: β TBD.
Quick call?
PSβnext bottleneck hits β TBD.
DM β€45 words, TONE:
Saw your post about $20M Series A financing β long waits for prescriptions frustrate patients.
Self-serve rapid vision-testing kiosks deliver doctor-verified prescriptions in under 2 minutes. 90-second vision tests verified by licensed doctors.
Quick chat?